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ABSTRACT
Endothelial cells (ECs) line the insides of blood vessels and play a key role in the coagulation
and vascular repair system. Under normal circumstances, ECs are constantly expressing
anticoagulants to prevent clots and maintain healthy blood flow. But when there is an injury to
the vessel, endothelial cells become centrally involved in orchestrating the complex series of
events that would lead to the clotting of the wound. Thus, ECs are dynamic and respond
accordingly based on changes in their local environment. Unfortunately, endothelial cells can
sometimes misinterpret cues from the environment and initiate coagulation when there is no
vessel damage to repair, causing unwanted clots. This phenomenon was recently observed
among astronauts who have spent prolonged time in a weightless environment. More research is
needed to better understand how endothelial cells respond to microgravity conditions. This paper
focuses on building an mRNA-sequencing pipeline for analyzing the gene expression of
endothelial cells.
Keywords: Microgravity, Endothelial cells, mRNA-sequencing (RNA-seq), Transcription
profiling
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I. INTRODUCTION
Space exploration is an exciting and growing field, and there are ambitious dreams to
send humans to the moon, Mars, and beyond. However, it is also not unknown that spaceflight
takes a heavy toll on the human body and there can be significant, lasting adverse effects. In a
recent 2019 study that followed a cohort of crew members to the international space station
(ISS), one particular health risk was brought to the forefront [1]. Of the 11 astronauts in the
study, it was found that six of them demonstrated stagnant or reversed flow in the internal jugular
vein (IJV), which is a risk factor for blood clots, and one member actually developed an
occlusive IJV thrombus during spaceflight. It is clear that we need to have a better understanding
of how weightlessness and fluid shift in space impact cardiovascular health and the risk of blood
clot formation.
The goal of this project is to construct an mRNA-sequencing (RNA-seq) pipeline for
analyzing the gene expression of endothelial cells (ECs) and, in particular, how venous EC
expression changes under microgravity and flow conditions. This is part of a larger study funded
by NASA Space Biology entitled "Thrombosis in Microgravity," whose goal is to investigate the
effects of microgravity and fluid flow rate on IJV thrombosis by conducting experiments using
human umbilical vein endothelial cells (HUVECs). Specifically, the study will focus on the
analysis of the EC transcriptome and differential expression of genes under the following four
conditions presented in Table 1.
No flow, 1g (control) Normal flow, 1g (protective)
No flow, microgravity Normal flow, microgravity
Table 1. Experimental conditions for endothelial cell culture
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Unfortunately, due to time constraints, experimental results from the study were not
available yet at the time of this writing, so public data from published papers will be used to
construct and validate the pipeline, with the understanding that it can be easily transferable to the
experimental data once it is ready.
1.1 Endothelial cells and the coagulation system
Endothelial cells line the insides of blood vessels and play a central role in the vascular
repair system, including the formation of clots to stop bleeding upon injury. Blood clots, or
thrombuses, are formed from a combination of platelets and a mesh of fibrin proteins. During
clotting, the Von Willebrand factor helps adhere platelets to the wound site. At the same time, an
enzyme called Factor X is activated to form Factor Xa, which catalyzes the formation of
thrombin. Thrombin plays a role in platelet aggregation and fibrin formation, effectively forming
a blood clot [2].
Under normal circumstances, ECs are constantly expressing antiplatelets and
anticoagulants to prevent clots and maintain healthy blood flow. One of the key genes involved
in this process is TFPI (Tissue Factor Pathway Inhibitor), which codes for a protease inhibitor
that inhibits Factor Xa. Other anticoagulants expressed by the endothelial cells include
thrombomodulin, EPCR, and heparin-like proteoglycans [2].
There are many external factors that can trigger the endothelial cells to switch from an
anticoagulation state to thrombus formation. This includes physical damage to the vessel wall,
but also more subtle shifts in the vascular environment, such as changes in oxygen availability,
pressure, and shear stress [2]. The Virchow triad describes three factors that can increase the risk
of venous thrombosis, one of which is slowed blood flow or stasis. The lack of flow causes the
2
mRNA-SEQUENCING PIPELINE FOR DIFFERENTIAL GENE EXPRESSION ANALYSIS
pooling of procoagulant factors, such as thrombin, which promotes thrombosis [3]. Stasis is a
cause for concern in microgravity environments like during spaceflight.
1.2 RNA-seq analysis tools and workflow
One way to investigate how endothelial cells respond differently to various external
conditions is to perform RNA-seq analysis. The presence of mRNA indicates which genes are
being expressed at a given moment. By quantifying how much mRNA is present and comparing
their abundance between control and treatment conditions (e.g., normal vs. microgravity), we can
see how certain genes become differentially expressed as a result of a changed condition.
Once the mRNA have been sequenced in the lab, the RNA-seq analysis process usually
consists of quality assurance steps, mapping the sequenced reads to a reference genome, and
performing differential expression analysis. There are multiple tools available that can be used to
conduct each part of this process. Put together, they form the analysis pipeline.
1.2.1 Assessing read quality
The raw sequenced mRNA reads are usually provided in a FASTQ format, which stores
both the nucleotide sequence and the associated quality score for each base. The first step is to
evaluate the quality of the sequencing reads and identify any potential issues that may affect the
downstream analysis. FastQC is a quality control tool that takes FASTQ files as input and
generates summary metrics about the reads, including the per base sequence quality, sequence
duplication levels, and adapter content [4]. The report is outputted as an HTML file, which
displays the results as statistics and summary tables and graphs. FastQC was chosen for its ease
of use, simplicity, and easy to interpret output.
Based on the quality assessment, measures can then be taken to address any problematic
issues, such as trimming adapters and low-quality sequences as well as removing duplicate reads.
3
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1.2.2 Trimming adapters and low-quality sequences
During sequencing, the accuracy of base calls often drops towards the end of the read due
to the accumulation of errors that may occur along the way [5]. This would be indicated by the
quality score associated with each base in the FASTQ file. Another issue that can occur during
the sequencing process is that for shorter sequences, the length of the fragment may be less than
the number of bases being sequenced, thus the sequencing can continue into the adapters that are
ligated to the ends of the fragment [6]. As a result, these reads can end up containing the adapter
sequences.
Trimmomatic is a flexible trimming tool that is able to address both low-quality reads and
adapter contamination [7]. One of its features include using a sliding window to detect where the
average quality of the bases fall below a certain threshold, and cutting the read at that point. It
can also trim user-provided adapter sequences from the reads by aligning the two and clipping
the reads if the mismatch is below a specified threshold. In addition, Trimmomatic has several
other trimming options, including dropping reads below a certain length, which may be useful
for more robust alignments in the subsequent mapping step.
1.2.3 Mapping reads to the genome
Once the quality of the sequencing reads have been assured, the next step is to map them
to a reference genome to determine where the sequences originated from. Since the reads come
from RNA sequences and not DNA, it is crucial to take into account any splicing that may have
occurred. Mature mRNA will have undergone several processing steps post-transcription, which
includes the removal of introns, so the resulting reads will not be able to be mapped directly to
the genome without consideration of the splice sites.
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Luckily, there are various tools available that are designed to be able to map RNA reads
back to non-contiguous parts of the genome. STAR is the splice-aware aligner chosen for this
project because of its speed and accuracy [8]. STAR works by attempting to map each read as far
as it can to a contiguous portion of the genome, then repeating the process but only for the
remaining unmapped portion of the read, thus effectively cutting down on runtime, as compared
to other algorithms that attempt to find all possible full read matches. Although STAR is fully
able to detect splice junctions on its own, its accuracy can further be improved by providing a
gene annotation file that identifies the specific splice sites. STAR also provides the capability to
generate genome index files prior to mapping, which helps save time and memory during the
mapping process.
The output is an alignment file that stores each read with its alignment to the reference
genome, along with additional information like mapping quality scores. The file can be outputted
as Sequence Alignment Map (SAM) format, or the compressed binary form, Binary Alignment
Map (BAM) format, which can save disk space. A read can either be mapped uniquely to one
location of the genome, mapped to multiple locations if it is ambiguous where it came from, or
unmapped if no alignments can be confidently determined. STAR provides options to specify
whether and to what extent to retain unmapped reads or multi-mapped alignments in the SAM or
BAM file.
1.2.4 Removing duplicate reads and assessing alignment quality
During the RNA-seq library preparation process, the sequences typically undergo PCR
amplification to produce enough copies to be detectable by the sequencing machine. But due to
PCR biases, not all sequences may be amplified equally [9], which can lead to misleading results
later down the road during read quantification, as overrepresented sequences can falsely give the
5
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impression of higher expression levels. Another potential source of duplication can occur during
the sequencing process itself, where a single clonal cluster being sequenced might be
misinterpreted as multiple clusters, resulting in what are known as optical duplicates. It is
important to account for these errors and biases in order to accurately quantify the reads.
Picard is a collection of command-line tools for working with sequencing data in formats
such as SAM or BAM [10]. It includes a program called MarkDuplicates that is capable of
flagging and removing duplicates by checking for reads that align to the same positions of the
genome, which is unlikely to occur by chance since sequence fragmentation was random, and
retaining the read with the highest base quality [11]. An advantage of removing duplicates at this
stage of the pipeline using the aligned reads instead of directly comparing the raw reads for exact
matches is that it is not limited by any sequencing errors that may have occurred.
In order to use MarkDuplicates, the input alignment file must be sorted. If it is sorted by
coordinates, the tool will not mark the unmapped mates of mapped records or any secondary or
supplementary alignments as duplicates, whereas it can if the file was sorted by query name.
Picard includes a tool in its collection called SortSam for sorting SAM and BAM files [12]. It
comes with the option of generating an accompanying index file that can speed up file lookup.
Sorting and indexing the alignment file is useful to make accessing the contents of the file faster
for downstream tools. In addition, Picard also provides several programs for collecting quality
metrics about the alignment files. Its CollectMultipleMetrics tool is able to call on these
programs in a single step to collect multiple types of metrics [13].
1.2.5 Quantifying reads
Once the quality of the alignments have been assured, the reads can be quantified to
determine how many reads are mapped to each gene in the reference genome. featureCounts is a
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quantification tool that takes SAM or BAM files as input, as well as the corresponding gene
annotation file, and generates the raw counts of reads mapped per genomic feature [14]. For
paired-end data, it is able to count each pair of reads once as a single fragment rather than
separate reads. Internally, featureCounts will sort the alignment file by query name such that the
paired reads always follow one another consecutively, so the input file does not necessarily have
to be pre-sorted.
featureCounts works by quantifying the alignments between the reads and the genomic
features provided in the annotation file. It can generate counts for features such as exons or
broader, meta-features like genes, which would be the interest of this project. When quantifying
to the meta-feature level, only the number of overlaps with each meta-feature is counted. For
example, even if a read spans multiple exons, it would only contribute one count towards the
overarching gene. Multi-mapping reads that were mapped to more than one location in the
genome are not counted at all by default. In addition, if a read overlaps multiple genes,
featureCounts by default does not count that read as there is not enough confidence to attribute it
to any one gene. However, in the case of paired-end data, if there is ambiguity involving multiple
genes, featureCounts further checks to see if there is one gene that overlaps both reads in the pair
while the other overlaps just one read, in which case there is enough confidence to count the read
towards the former.
Compared to other quantification tools, featureCounts works particularly well for
paired-end data because of its ability to potentially resolve ambiguity for fragments overlapping
multiple genomic features. featureCounts is also much faster and less memory intensive than
similar tools [14].
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1.2.6 Differential gene expression analysis
After the quantification step, gene-level differential expression (DE) analysis can be
performed to identify any genes that are expressed in significantly different amounts between
samples under different conditions. DESeq2 is an R package that takes raw counts data as input
and provides functions for detecting differential expression [15]. Raw counts data from RNA-seq
experiments will typically have a heavily right-skewed distribution, where a majority of the
genes have very few counts, while few genes are highly expressed. In addition, the variance
across samples for each gene tends to become larger than the mean, particularly for genes with
high mean expression levels. These criteria make the Negative Binomial distribution an ideal
approximation for RNA-seq counts, which is what DESeq2 uses to model the data [16].
For a gene to be considered differentially expressed between treatment and control
groups, the mean expression level should be significantly different between the groups, while the
variation within a group is minimal. Internally, DESeq2 normalizes the raw counts to account for
the differences in sequencing depth and RNA library composition to make the samples
comparable with each other. It is not necessary to account for gene length since comparison is
not done across genes [16]. To estimate the variation in the data, DESeq2 calculates the
dispersion for each gene, which is a better measure than the variance. As mentioned previously,
the variance tends to be lower for genes with low mean expression, making it easier for genes
with low counts to be identified as differentially expressed. On the other hand, the dispersion
accounts for the variation at different mean expression levels [16].
Once the data is optimized and the model is fit, DESeq2 performs hypothesis testing
using the Wald test to determine whether there is a significant difference in the mean expression
between the treatment and control groups for each gene. The difference in expression is
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measured as a log2 fold change (LFC), where the null hypothesis assumes a LFC of 0. Among
other statistics, DESeq2 returns the LFC, associated p-value, as well as the adjusted p-value for
each gene. The adjusted p-value, corrected by the Benjamini-Hochberg method, represents the
false discovery rate (FDR) of identifying a gene as differentially expressed [16]. It should be
used during multiple hypothesis testing when multiple genes are tested at the same time.
1.2.7 Gene set enrichment and pathway analysis
In addition to identifying individual DE genes, gene set enrichment analysis (GSEA) can
be conducted to detect whether groups of genes belonging to known pathways are significantly
enriched or depleted. Sometimes, individual genes might not be determined as differentially
expressed according to some significance threshold, but put together, genes from a common
pathway can show an overall significant difference in expression at the gene set level [17].
To perform GSEA, the genes must first be ranked according to their differential
expression, where genes at the top and bottom of the list are those that are highly upregulated or
downregulated, and genes in the middle are those without significant difference in expression.
Common metrics for ranking include using the shrunken LFC, Wald test statistic, or signed
p-value. For a gene set to be considered enriched or depleted, the genes belonging to that set
should be found mostly near the top and bottom of the ranked list, rather than randomly
distributed across the list. An enrichment score (ES) is calculated to measure how well the genes
of a gene set are aggregated near the extremes of the list, with a positive value indicating they are
mostly distributed near the top of the list and a negative value indicating they are mostly at the
bottom. The normalized enrichment score (NES) accounts for gene set size and other factors to
make it comparable across gene sets. An associated adjusted p-value is also calculated to
represent the FDR of a gene set being identified as enriched [18].
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fgsea is an R library for performing GSEA [19]. It takes a ranked list of genes and
collection of gene sets as input and outputs the ES, NES, and adjusted p-value, among other
statistics. It can also generate enrichment plots and summary tables for being able to quickly
visualize results.
1.2.8 Aggregating log files
During each step in the pipeline, there may be output or log files produced by the various
tools for each sample. This can quickly amount to a significant number of files, making it
difficult to manually check on each one. MultiQC is a results aggregation tool that is able to
compile the output files from multiple tools into a single HTML report [20]. It is able to
recognize and parse files from a wide variety of common Bioinformatics tools and display
summarized statistics and interactive plots. For example, FastQC, STAR, and featureCounts are
among the many tools supported by MultiQC. The resulting aggregated report makes it easy to
quickly assess the outputs across all samples, from read quality to mapping and quantification
results.
1.2.9 Workflow management system
To help manage the workflow, Snakemake was used as the Bioinformatics pipeline
framework [21]. Having a framework not only allows the user to run the complete set of tools
together in a pipeline, but also provides additional options and flexibility, such as the ability to
run steps in parallel and easily swap out files and settings using a configuration file. In addition,
if the pipeline fails at a particular point or change is made to only one part of the pipeline, the
system would be able to detect and rerun only the affected portions, thus saving time and
increasing efficiency.
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With Snakemake, each step in the pipeline is defined as a rule that specifies the expected
inputs and outputs as well as the shell command or script for running that step. For each rule, an
isolated software environment can also be defined to be able to use specific versions of the tools
involved at that step. Newer versions of Snakemake use mamba by default to install conda
packages, which is a faster and more robust reimplementation of the conda package manager.
This helps make Snakemake workflows highly scalable and reproducible.
To run the pipeline, the Slurm Workload Manager was used to schedule jobs and allocate
resources on the San Jose State University (SJSU) High Performance Computer (HPC) cluster
[22]. Snakemake also has the capability to integrate the execution of workflows on a cluster.
II. DATA AND METHODS
2.1 Data
To test and validate the pipeline, RNA-seq data from two recent papers were used. The
first dataset was specifically chosen to be one that is studying the effects of microgravity, as it
relates to the scope of the original project, while the second is a more general dataset.
Furthermore, the datasets were selected to contain both mRNA and miRNA sequencing data,
since the original project will be studying both, to allow for exploratory analysis of the
interaction between mRNA and miRNA. This limits the available datasets to only one mouse
dataset for the first paper, which is why mouse data was used to test the pipeline.
2.1.1 Paper #1
The first dataset comes from a 2021 paper entitled "Cerium oxide nanoparticle
administration to skeletal muscle cells under different gravity and radiation conditions" by
Genchi et al. that was published in ACS Applied Materials & Interfaces [23]. The
mRNA-sequencing reads data is available in NCBI’s Gene Expression Omnibus (GEO) database
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(GSE165565), along with the raw counts data outputted from the quantification step, which can
be used to validate the project pipeline results.
In this study, the authors aimed to understand the effects of cerium oxide nanoparticles
("nanoceria") on the transcriptome of skeletal muscles under various gravity and radiation
conditions. Table 2 shows all the experimental conditions of the paper, but this project will only
focus on the samples without nanoceria treatments (i.e., experimental class type A, C, E), as that
is outside the scope of this project.
experimental_class_type regime treatment
A in space without gravity without nanoceria
B in space without gravity with nanoceria
C in space with gravity without nanoceria
D in space with gravity with nanoceria
E on land without nanoceria
F on land with nanoceria
Table 2. Experimental conditions for Paper #1
C2C12 mouse myoblasts (ATCC CRL-1772) were used in this study, with three
biological replicates for each experimental class type. The cell cultures for class A and C were
sent on board the International Space Station (ISS), whereas those for class E remained on Earth.
Further, the samples for class C underwent centrifugation to simulate 1μ gravity on Earth, while
still receiving the exposure of cosmic radiation in space. This yields three possible pairwise
comparisons to explore the effects of microgravity and space radiation (A vs. E), only radiation
(C vs. E), and only microgravity with a background of radiation (A vs. C). This project will
focus on the two related to microgravity.
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Total RNA extraction was performed using the MirVana PARIS kit (Ambion AM1556),
and mRNA was isolated via poly-A tail selection and the sequencing libraries were prepared
using the NEBNext Ultra RNA Library Prep Kit for Illumina. The samples were sequenced on
the Illumina HiSeq 2500 System using a 2x150bp paired-end configuration.
2.1.2 Paper #2
The second dataset comes from a 2021 paper entitled "Transcriptional Network Analysis
Reveals the Role of miR-223-5p During Diabetic Corneal Epithelial Regeneration" by Zhang et
al. that was published in Frontiers in Molecular Biosciences [24]. The mRNA-sequencing reads
data is available in NCBI’s Gene Expression Omnibus (GEO) database (GSE180490).
In this study, the authors aimed to understand the mechanisms by which hyperglycemia
(high blood glucose) leads to a loss of corneal epithelial regeneration function. Six-to-eight
weeks old male C57BL/6 mice were used in the study, with half of them given streptozotocin
(STZ) injections for five days to induce Type 1 diabetes. After 16 weeks from the final injection,
the diabetic mice with a blood glucose level of over 25 mmol/L were selected. Three biological
replicates were used each for the treatment and control groups.
To obtain the samples for RNA-sequencing, the corneal epithelium of the mice were first
removed, then samples of the regenerative corneal tissues were collected after 24 hours of the
injury. The mRNA library was prepared using the KAPA Stranded RNA-Seq Library Prep Kit
and sequenced on the Illumina NovaSeq 6000 System using a 2x150bp paired-end configuration.
13
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2.2 Methods
A summary of the workflow for the RNA-seq pipeline is shown in Figure 1, along with
the tool versions below.
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The full pipeline was run on the SJSU HPC using Snakemake. There are 72 compute
nodes available on the HPC. Each node has 2 CPUs, and there are 14 cores per CPU for a total of
28 cores per node. There is also 128GB of RAM per node. In an attempt to reproduce the paper's
results, the same tools and versions of the tools used in the first paper were used in this pipeline,
though this was limited to what was presented in the paper. Since conda environments were used
for each rule, this can be easily updated as needed.
The raw mRNA-sequencing reads for both papers were downloaded from the GEO
database, with a total of nine samples from the first paper and six samples from the second.
Because these are all paired-end data, there were two FASTQ files for each sample. Both the
forward and reverse reads for each sample underwent quality assessment using FastQC. Among
other metrics, the adapter content was checked to see what sequences need to be trimmed.
Trimmomatic was used to trim the adapters and low-quality sequences. FastQC identified
the adapters to be the Nextera Transposase Sequence and Illumina Universal Adapter, and the
respective sequences were obtained from the Trimmomatic GitHub repository for trimming [25].
In addition, a Phred quality score threshold of 20 was used to clip the reads where the quality
starts to drop within a sliding window of 4 bases. A Phred score of 20 corresponds to a 1% error
rate, which is considered acceptable for most purposes [26]. A minimum read length of 20bp was
also used to filter out short reads that can cause ambiguity during the mapping process. The
trimmed FASTQ files were again evaluated using FastQC to ensure the trimming generated the
expected results.
Once the trimmed reads were satisfactory, they were mapped to the reference genome
using STAR. Following the first paper, the mouse reference genome GRCm38.p6 was used. The
primary assembly genome FASTA file and corresponding gene annotation GTF file were
15
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obtained from Ensembl for the first paper [27] and UCSC Genome Browser for the second [28],
as that is what produced the most consistent results when compared to the respective papers. The
reference genome and annotation files are specified in the configuration file of the Snakemake
pipeline, so it can be easily swapped out for each run.
The reference genome was first indexed using STAR. Since STAR is a splice-aware
aligner, it simultaneously constructs a splice junctions database given the annotation file. To
optimize the performance of the mapping, the STAR manual recommends specifying the
maximum read length minus one as the number of bases around the junction sites to be used
while creating the database. Since the data from both papers used a 2x150bp configuration, the
reference genome was indexed using an overhang of 149. After mapping, the alignment files
were outputted as BAM files to save disk space.
The BAM files were then sorted by coordinate position and indexed. Coordinate-sorting
was used over sorting by query name because it is the preferred ordering for many visualization
tools like the Integrative Genomics Viewer (IGV). As mentioned previously, MarkDuplicates
will not mark the unmapped mates of mapped records or any secondary or supplementary
alignments as duplicates when the file is sorted by coordinates. However, this does not have an
effect on the subsequent quantification step because featureCounts does not by default look at
unmapped reads or multi-mapped reads. Additionally, featureCounts will internally sort the
alignment file by query name, so it is not required to provide the input sorted as such.
When quantifying reads, featureCounts also considers the strandedness of the reads.
Depending on how the sequencing libraries were prepared, the forward and reverse reads may be
marked to come from a specific strand of the DNA. The data from the first paper was determined
to be unstranded, while the data from the second paper was reversely stranded. The
16
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infer_experiment.py script from RSeQC was used to confirm the strandedness of the libraries
[29].
Differential expression analysis was conducted using DESeq2 to identify genes that are
significantly upregulated or downregulated between the treatment and control groups. An
adjusted p-value of 0.05 was used as the significance threshold for analysis of both papers' data.
In addition, the first paper used an absolute LFC of above 1 as a criteria for identifying DE
genes, and the second paper used an absolute LFC of above 0.585 as well as a mean fragments
per kilobase per million (FPKM) greater than 0.5 as their criteria, so these were applied to the
respective analyses of the data as well. For the first paper, the raw counts file from their
quantification step was available for download, so that was also obtained and run through the DE
analysis to use as comparison.
For GSEA, the Molecular Signatures Database (MSigDB) provides nine major
collections of gene sets, including the Hallmark gene sets for common biological pathways and
the Gene Ontology (GO) gene sets, with the more specific Biological Process (BP), Cellular
Component (CC), and Molecular Function (MF) subcomponents. These gene sets are available in
R format for mouse data from Walter and Eliza Hall Institute (WEHI) [30]. Because these gene
sets use Entrez ID's instead of Ensembl ID's, conversions between the gene ID's were obtained
using the R package biomaRt [31]. Conversions between Ensembl ID and gene symbols were
also obtained to be able to compare with the second paper's results, as those were presented using
gene symbols. The Wald test statistic was used to rank the genes for the analysis. An adjusted
p-value of 0.25 was used as the significance threshold for identifying enriched gene sets, as that
is generally considered acceptable for exploratory GSEA [18].
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III. RESULTS
3.1 Paper #1
Raw RNA-seq data from nine samples were downloaded for the first paper by Genchi et
al. The total number of paired-end reads as well as the experimental condition for each sample is
shown in Figure 2.
Figure 2. Raw read counts per sample, Paper #1
3.1.1 Trimming results
For the first paper's data, FastQC identified the adapter sequence as Nextera Transposase
Sequence, and this was successfully removed using Trimmomatic, as seen in Figure 3. After
removing low-quality sequences and short sequences, over 90% of the reads still remained in all
samples, as seen in Figure 4.
Figure 3. Adapter content before and after trimming, Paper #1
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Figure 4. Trimming results, Paper #1
3.1.2 Mapping results
As seen in Figure 5, between 40-70% of the reads that survived the trimming step were
uniquely mapped to the reference genome, which corresponds to at least 9M reads in each
sample. There is also a relatively high proportion of reads that were unmapped, over 50% in
some cases. The unmapped reads were largely classified by STAR as being too short, which by
default is defined as alignments where less than two thirds of the read is mapped. It is possible to
adjust this criteria to something less stringent to increase the number of mapped reads, however,
this may lead to more inaccurate mappings, so that was not done. Furthermore, there are enough
reads remaining to proceed confidently with the rest of the downstream analysis.
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Figure 5. Mapping results, Paper #1
3.1.3 Deduplication results
Figure 6 shows the percentage of mapped reads that survived after removing duplicates.
Only mapped reads are considered by MarkDuplicates because duplicate removal is done by
comparing the start and end positions of the alignments. The number of mapped reads include
reads that are uniquely mapped and reads that are multi-mapped by STAR.
For example, there are approximately 18M mapped reads for sample SRR13535276, over
73% of which are identified and removed by MarkDuplicates as duplicate reads.
Figure 6. Deduplication results, Paper #1
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3.1.4 Quantification results
Figure 7 shows the final number of read pairs that were assigned to a gene by
featureCounts, relative to the original number of raw reads that each sample started with. This is
the total number of reads that made it to the differential gene expression analysis. As seen, at
least 1.5M reads were ultimately quantified for each sample.
Figure 7. Quantification results, Paper #1
3.1.5 Differential gene expression results
For the A vs. C comparison (in space without gravity vs. in space with gravity),
differential expression analysis identified 81 DE genes (9 upregulated and 72 downregulated).
Using the paper's raw counts data to run the same analysis, 67 DE genes (7 upregulated and 60
downregulated) were identified. This is compared to the 61 total DE genes (9 upregulated and 52
downregulated) that the paper reported in the text. Because the paper only reported the number
and not names of the DE genes they found, the 67 DE genes identified from using the paper's
raw counts data were compared to the 81 identified by this project. As seen in Figure 8, the
project identified 56 of the paper's 67 DE genes (83.6%), in addition to 25 additional DE genes.
21
mRNA-SEQUENCING PIPELINE FOR DIFFERENTIAL GENE EXPRESSION ANALYSIS
Figure 8. DE genes identified by project vs. paper for A vs. C comparison, Paper #1
For the A vs. E comparison (in space without gravity vs. on land), the project identified
496 DE genes (312 upregulated and 184 downregulated). Using the paper's raw counts data, 343
DE genes (239 upregulated and 104 downregulated) were identified. This is compared to the 343
total DE genes (230 upregulated and 113 downregulated) reported in the text. As seen in Figure
9, the project identified 295 of the 343 DE genes identified from using the paper's raw counts
data (86.0%), in addition to having 201 additional DE genes.
Figure 9. DE genes identified by project vs. paper for A vs. E comparison, Paper #1
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In general, the project was able to identify a majority of the same DE genes identified
from using the paper's raw counts data. The project also seemed to identify a greater number of
DE genes using the same significance level of 0.05 and LFC of greater than 1 criteria.
3.1.6 Gene set enrichment and pathway results
For the A vs. C comparison (in space without gravity vs. in space with gravity), GSEA
results from using the paper's counts data and the project are largely similar. Figure 10 shows the
top 10 most enriched and top 10 most depleted Hallmark gene sets from the project (top) and
paper (bottom). Common enriched gene sets include the epithelial mesenchymal transition
pathway at the top and depleted gene sets include protein secretion at the bottom.
Figure 10. Top Hallmark gene sets identified by project (top) vs. paper (bottom) for A vs. C
comparison, Paper #1
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For the A vs. E comparison (in space without gravity vs. on land), both the project and
paper data identified the myogenesis pathway as being significantly depleted, with an adjusted
p-value of well below 0.25, as seen in Figure 11. Myogenesis is defined as the formation of
skeletal muscles. This suggests that muscle atrophy could be an adverse effect of space, which is
widely cited in literature. Interestingly, the results also show the epithelial mesenchymal
transition pathway being depleted and the protein secretion being enriched, which is the opposite
of what was observed for the A vs. C comparison.
Figure 11. Top Hallmark gene sets identified by project (top) vs. paper (bottom) for A vs. E
comparison, Paper #1
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3.2 Paper #2
Raw RNA-seq data from six samples were downloaded for the second paper by Zhang et
al. The total number of paired-end reads as well as the experimental condition for each sample is
shown in Figure 12.
Figure 12. Raw read counts per sample, Paper #2
3.2.1 Trimming results
For the second paper's data, FastQC identified the adapter sequence as Illumina Universal
Adapter, and this was successfully removed using Trimmomatic, as seen in Figure 13. After
removing low-quality sequences and short sequences, over 95% of the reads still remained in all
samples, as seen in Figure 14.
Figure 13. Adapter content before and after trimming, Paper #2
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Figure 14. Trimming results, Paper #2
3.2.2 Mapping results
As seen in Figure 15, over 75% of reads that survived the trimming step in each sample
were uniquely mapped to the reference genome. There are relatively low proportions of
multi-mapped and unmapped reads, suggesting that the quality of the reads is high with few
contaminations.
Figure 15. Mapping results, Paper #2
3.2.3 Deduplication results
Figure 16 shows the percentage of mapped reads that survived after removing duplicates.
Generally, less than half of the reads were removed as duplicates.
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Figure 16. Deduplication results, Paper #2
3.2.4 Quantification results
Figure 17 shows the final number of read pairs that were assigned to a gene by
featureCounts, as compared to the original number of raw reads that each sample started with. At
least 8M reads were ultimately quantified for each sample.
Figure 17. Quantification results, Paper #2
3.2.5 Differential gene expression results
267 DE genes (157 upregulated and 110 downregulated) were identified in the project,
compared to the 186 DE genes (94 upregulated and 92 downregulated) reported in the paper. The
paper provided a list of the DE genes they identified as part of their supplementary data. Figures
18 and 19 show the overlap between the upregulated and downregulated DE genes identified by
the project and the paper.
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Figure 18. Upregulated genes identified by project vs. paper, Paper #2
Figure 19. Downregulated genes identified by project vs. paper, Paper #2
As seen, the project was able to identify 72 of the paper's 94 upregulated genes (76.6%)
and 66 of the paper's 92 downregulated genes (71.7%). In addition, the project identified
additional genes as being differentially expressed. One thing to note is that the paper provided
the list of genes by their gene symbol, whereas the project output used Ensembl gene ID.
Conversions between the two were obtained using biomaRt, but they may be missing for some
genes, which can contribute to some of the lack of overlap.
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Figure 20 shows the volcano plot, which highlights the DE genes in color. As mentioned
previously, an adjusted p-value of 0.05 and LFC threshold of 0.585 were used to identify DE
genes, which can be seen in the plot. The labelled genes – Sod3, Igf2, Ctgf, and Hmga2 – are
ones that are identified in existing literature to be upregulated or downregulated in diabetic
patients. The findings are consistent between the paper (left) and project (right) results.
Figure 20. Volcano plot for paper (left) vs. project (right), Paper #2
3.2.6 Gene set enrichment and pathway results
GSEA was performed, and findings are also consistent with what was reported in the
paper. For example, Hallmark pathways involved in immune response are enriched, including the
inflammatory response, as seen in Figure 21. Glycolysis was also heavily depleted, which aligns
with the fact that the treatment mice were diabetic. Among the GO Biological Process (BP) gene
sets shown in Figure 22, the DE genes appear to be involved in pathways related to the immune
response as well as epithelial regeneration and carbohydrate metabolism.
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Figure 21. Top Hallmark gene sets, Paper #2
Figure 22. Top GO Biological Process (BP) gene sets, Paper #2
IV. DISCUSSION
4.1 Removing duplicates
DE analysis was performed with and without removing duplicate reads. When duplicates
are not removed, more DE genes tend to be identified, which naturally leads to more overlap
with the papers' results. However, the increase in overlap is minimal compared to the number of
additional DE genes the project identified that the paper did not commonly identify. As a more
conservative approach, duplicates were removed as a way to reduce potential false positives.
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4.2 Interacting factors
As seen in the GSEA results for the first paper, some results are contradicting between
the pairwise comparisons. Specifically, certain pathways enriched in the A vs. C comparison are
depleted in the A vs. E comparison, and vice versa. The first paper reported this phenomenon as
well, explaining that the effects of microgravity and radiation may be opposing. This shows that
it may be helpful to study multiple factors at the same time to see how they interact, such as the
effects of microgravity in combination with different flow rates.
4.3 Pipeline validation
Data from two papers were used to test and validate the pipeline in this project. Broad
findings and results were consistent between the project and paper data, however there are some
discrepancies, which can be caused by differences in the tools and settings used along each step
in the pipeline. In a real experiment, it may be useful to try out various tools to see how the end
results compare and identify consistencies between the runs. The current mRNA-sequencing
pipeline is designed to be flexible to swap out tools and versions of tools at each step, as well as
adjust parameters using the configuration file.
4.4 Pipeline runtime
The pipeline also fully takes advantage of Snakemake and Slurm to produce a workflow
that can be run in parallel for optimal efficiency. Figure 23 shows the time it takes to run the
pipeline for the first (top) and second (bottom) papers. To make them more comparable, the
maximum number of jobs to be run in parallel for each paper was limited to the number of
samples they have, or 9 jobs for the first paper and 6 for the second. All steps were run with the
default of 1 CPU core.
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Figure 23. Pipeline runtime for Paper #1 (top) and Paper #2 (bottom), 1 CPU core per rule
As seen, the first paper took a little over three hours and the second paper took a little
under three hours to run. It makes sense that the first paper would take longer given that its
samples contain more reads. Being able to run the samples in parallel already significantly
reduced the total runtime, as running each step for each sample sequentially could take upwards
towards a full day to run.
From Figure 23, it can also be seen that the trimming and mapping steps take the longest
time to run. Luckily, both Trimmomatic and STAR support multithreading, so more CPU cores
can be allocated to them in the pipeline to speed up the runtime.
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Figure 24. Pipeline runtime for Paper #1 (top) and Paper #2 (bottom), multithreading
Figure 24 shows the resulting pipeline runtime when more cores were used for the tools
that support multithreading. Specifically, two cores were allocated to run FastQC, and 14 cores
each were allocated to run Trimmomatic, STAR, and featureCounts. As seen, this helped cut
down the total runtime in half.
4.5 Code and data availability
All code and documentation of the data used can be found in the GitHub repository here.
Select outputs from the pipeline for the two papers' data, including the raw counts file and all
generated reports, can be found here.
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